Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Diabetes Mellitus and Risk of Plasma Cell and Lymphoproliferative Disorders: A Population Based Study Including 94,579 Cases and 368,348 Matched Controls

Urvi A Shah, MD, Sæmundur Rögnvaldsson, BS, Andriy Derkach, PhD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Yael David, PhD, Malin Hultcrantz, MD PhD, Carlyn Tan, MD, Hani Hassoun, MD, Neha Korde, MD, Alexander M. Lesokhin, MD, Sham Mailankody, MBBS, Sigurður Yngvi Kristinsson, MD PhD, Ola Landgren, MD PhD

Blood (2020) 136 (Supplement 1): 44–45.

https://doi.org/10.1182/blood-2020-141597

Published: 2020

Journal Articles

Serum Metabolomic Profiling Correlated with ISS and Clinical Outcome for Multiple Myeloma Patients Treated with High Dose Melphalan and Autologous Stem Cell Transplantation

Ljupco Veskovski, MD, Per-Ola Andersson, MD PhD, Ingemar Turesson, MD PhD, Daniel Malmodin, PhD, Anders Pedersen, PhD, Ulf-Henrik Mellqvist, MD PhD

Blood (2019) 134 (Supplement_1): 1771.

https://doi.org/10.1182/blood-2019-121961

Published: 2019

Journal Articles

Peripheral Neuropathy in MGUS and Progression to Amyloid Light-Chain Amyloidosis: A Population-Based Study Including 15,351 MGUS Cases

Sæmundur Rögnvaldsson, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2019) 134 (Supplement_1): 5444.

https://doi.org/10.1182/blood-2019-131514

Published: 2019

Journal Articles

Risk Factors for Acute Myeloid Leukemia and Myelodysplastic Syndromes in Patients with Multiple Myeloma: An Updated Analysis

Gudbjorg Jonsdottir, MD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Malin Hultcrantz, MD PhD, Anna Porwit, MD PhD, Yogesh Jethava, MBBS, MD FRCPath, MRCP, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 4437.

https://doi.org/10.1182/blood-2018-99-111715

Published: 2018

Journal Articles

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Sigrun Thorsteinsdottir, MD, Ingigerdur S Sverrisdottir, MD, Gauti Gislason, MSc, Ola Landgren, MD PhD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Sigurdur Y Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 4490.

https://doi.org/10.1182/blood-2018-99-115403

Published: 2018

Journal Articles

Peripheral Neuropathy Is Associated with an Increased Risk of Fractures in Individuals with Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study Including 15,351 MGUS Cases

Sæmundur Rögnvaldsson, BS, Sigrun Thorsteinsdottir, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 1914.

https://doi.org/10.1182/blood-2018-99-116740

Published: 2018

Journal Articles

Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

Gudbjorg Jonsdottir, MD, Magnus Bjorkholm, MD PhD, Ingemar Turesson, MD PhD, Malin Hultcrantz, MD PhD, Anna Porwit, MD PhD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Ola Landgren, MD PhD, Sigurdur Y. Kristinsson, MD PhD

Blood (2017) 130 (Supplement 1): 4396.

https://doi.org/10.1182/blood.V130.Suppl_1.4396.4396

Published: 2017

Journal Articles

Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls

Sæmundur Rögnvaldsson, Vilhjálmur Steingrímsson, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2017) 130 (Supplement 1): 4338.

https://doi.org/10.1182/blood.V130.Suppl_1.4338.4338

Published: 2017

Journal Articles

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Gudbjorg Jonsdottir, MD, Sigrún H. Lund, PhD, Magnus Björkholm, MD, PhD, Ingemar Turesson, MD, PhD, Anders Wahlin, MD, Prof., Malin Hultcrantz, MD, PhD, Anna Porwit, MD, PhD, Ola Landgren, MD, PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 3246.

https://doi.org/10.1182/blood.V128.22.3246.3246

Published: 2016

Journal Articles

Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study

Shaji Kumar, MD, Meletios A Dimopoulos, Efstathios Kastritis, MD, Evangelos Terpos, Hareth Nahi, Hartmut Goldschmidt, MD, Jens Hillengass, MD, Xavier Leleu, Meral Beksac, MD, Melissa Alsina, MD, Albert Oriol, MD, Michele Cavo, MD, Enrique M. Ocio, MD PhD, Maria Victoria Mateos, Elizabeth K. O'Donnell, MD, Ravi Vij, MD MBA, Henk M. Lokhorst, MD PhD, Niels W.C.J. van de Donk, MD PhD, Chang-Ki Min, Tomer Mark, MD MSc, Ingemar Turesson, MD, PhD, Markus Hansson, MD, Heinz Ludwig, Sundar Jagannath, MD, Michel Delforge, MD PhD, Charalampia Kyriakou, MD PhD, Parameswaran Hari, MBBS, MD MRCP, Ulf-Henrik Mellqvist, MD PhD, Saad Z Usmani, MD FACP, Dominik Dytfeld, MD PhD, Ashraf Z Badros, MD, Philippe Moreau, Kihyun Kim, MD PhD, Paula Rodriguez Otero, MD, Jae Hoon Lee, MD, Chaim Shustik, MD, Daniel Waller, PhD, Wee Joo Chng, MD PhD, Shuji Ozaki, MD PhD, Je-Jung Lee, Javier de la Rubia, Hyeon Seok Eom, MD PhD, Laura Rosinol, MD PhD, Juan José Lahuerta, MD PhD, Anna Sureda, MD PhD, Jin Seok Kim, MD PhD, Brian G.M. Durie, MD

Blood (2016) 128 (22): 4414.

https://doi.org/10.1182/blood.V128.22.4414.4414

Published: 2016

Journal Articles

GDF15 Promotes Osteoclast Differentiation and High Serum GDF15 Levels Are Associated with Multiple Myeloma Bone Disease

Marita Westhrin, MSc, Siv Helen Moen, PhD, Toril Holien, PhD, Oddrun Elise Olsen, MSc, Anne Kærsgaard Mylin, MDhD, Peter Gimsing, MD PhD, Ingemar Turesson, MD PhD, Anders Waage, MD PhD, Therese Standal, PhD

Blood (2014) 124 (21): 2065.

https://doi.org/10.1182/blood.V124.21.2065.2065

Published: 2014

Journal Articles

Patterns of Infectious Morbidity in Patients with Waldenström’s Macroglobulinaemia/Lymphoplasmacytic Lymphoma: A Population-Based Study

Sigrun Helga Lund, PhD, Malin Hultcrantz, MDPhD, Lynn Goldin, PhD, Ola Landgren, MD PhD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Sigurdur Y Kristinsson, MD, Ph., D

Blood (2014) 124 (21): 3350.

https://doi.org/10.1182/blood.V124.21.3350.3350

Published: 2014

Journal Articles

Impact Of History Of Autoimmune Disease On Survival In Multiple Myeloma and Monoclonal Gammopathy Of Undetermined Significance: A Population-Based Study

Ebba K Lindqvist, MD, PhD Student, Ingemar Turesson, MD, PhD, Ola Landgren, MD, PhD, Sigrún H Lund, PhD, Lynn Goldin, PhD, Magnus Bjorkholm, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2013) 122 (21): 1898.

https://doi.org/10.1182/blood.V122.21.1898.1898

Published: 2013

Journal Articles

Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011

Cecilie Blimark, MD, Erik Holmberg, PhD, Gunnar Juliusson, MD, PhD, Hareth Nahi, MD, PhD, Forsberg Karin, MD, PhD, Ingemar Turesson, MD, PhD, Lucia Ahlberg, MD., PhD., Ronald Svensson, MD, Olle Linder, MD, Kristina Carlsson, MD, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2013) 122 (21): 1972.

https://doi.org/10.1182/blood.V122.21.1972.1972

Published: 2013

Journal Articles

Multiple Myeloma Patients With Prior Knowledge Of MGUS Have a Better Survival Compared To Multiple Myeloma Patients Without Prior Knowledge Of MGUS

Elin Edda Sigurdardottir, Ingemar Turesson, MD, PhD, Sigrun Helga Lund, Ebba K Lindqvist, MD, PhD Student, Neha Korde, MD, Sham Mailankody, MD, Magnus Björkholm, MD, PhD, Ola Landgren, MD, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2013) 122 (21): 1984.

https://doi.org/10.1182/blood.V122.21.1984.1984

Published: 2013

Journal Articles

Monoclonal Gammopathy Of Undetermined Significance and Risk Of Lymphoid and Myeloid Malignancies: 743 Cases Followed For Up To 30 Years In Sweden

Ingemar Turesson, MD, PhD, Stephanie Kovalchik, Ruth M Pfeiffer, PhD, Sigurdur Y Kristinsson, M.D., Ph.D., Lynn Goldin, PhD, Mark Drayson, Ola Landgren, MD, PhD

Blood (2013) 122 (21): 3124.

https://doi.org/10.1182/blood.V122.21.3124.3124

Published: 2013

Journal Articles

Elevated Risk of Venous but Not Arterial Thrombosis in Waldenström's Macroglobulinemia and Lymphoplasmacytic Lymphoma

Malin L Hultcrantz, MD, Ruth M Pfeiffer, PhD, Magnus Bjorkholm, Lynn Goldin, PhD, Ingemar Turesson, MD, PhD, Sam Schulman, MD, PhD, Ola Landgren, M.D., Ph.D., Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2012) 120 (21): 1603.

https://doi.org/10.1182/blood.V120.21.1603.1603

Published: 2012

Journal Articles

Multiple Myeloma and Infections: A Population-Based Study Based On 9,610 Multiple Myeloma Patients

Cecilie Blimark, M.D., Ulf-Henrik Mellqvist, MD, PhD, Ola Landgren, M.D., Ph.D., Magnus Björkholm, MD, PhD, Malin L Hultcrantz, MD, Christian Kjellander, MD, Ingemar Turesson, MD, PhD, Erik Holmberg, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2012) 120 (21): 945.

https://doi.org/10.1182/blood.V120.21.945.945

Published: 2012

Journal Articles

Family History of Venous Thromboembolism As a Risk Factor for Thrombosis in Multiple Myeloma Patients: A Population-Based Study,

Sigurdur Y Kristinsson, M.D., Ph.D., Lynn Goldin, PhD, Ingemar Turesson, MD, PhD, Magnus Bjorkholm, MD, PhD, Ola Landgren, MD, PhD

Blood (2011) 118 (21): 3987.

https://doi.org/10.1182/blood.V118.21.3987.3987

Published: 2011

Journal Articles

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Sigurdur Y. Kristinsson, MD, PhD, Tang Min, PhD, Ruth Pfeiffer, PhD, Magnus Björkholm, MD, PhD, Lynn Goldin, PhD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, MD, PhD

Blood (2010) 116 (21): 4053.

https://doi.org/10.1182/blood.V116.21.4053.4053

Published: 2010

NARROW

Diabetes Mellitus and Risk of Plasma Cell and Lymphoproliferative Disorders: A Population Based Study Including 94,579 Cases and 368,348 Matched Controls

Serum Metabolomic Profiling Correlated with ISS and Clinical Outcome for Multiple Myeloma Patients Treated with High Dose Melphalan and Autologous Stem Cell Transplantation

Peripheral Neuropathy in MGUS and Progression to Amyloid Light-Chain Amyloidosis: A Population-Based Study Including 15,351 MGUS Cases

Risk Factors for Acute Myeloid Leukemia and Myelodysplastic Syndromes in Patients with Multiple Myeloma: An Updated Analysis

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Peripheral Neuropathy Is Associated with an Increased Risk of Fractures in Individuals with Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study Including 15,351 MGUS Cases

Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study

GDF15 Promotes Osteoclast Differentiation and High Serum GDF15 Levels Are Associated with Multiple Myeloma Bone Disease

Patterns of Infectious Morbidity in Patients with Waldenström’s Macroglobulinaemia/Lymphoplasmacytic Lymphoma: A Population-Based Study

Impact Of History Of Autoimmune Disease On Survival In Multiple Myeloma and Monoclonal Gammopathy Of Undetermined Significance: A Population-Based Study

Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011

Multiple Myeloma Patients With Prior Knowledge Of MGUS Have a Better Survival Compared To Multiple Myeloma Patients Without Prior Knowledge Of MGUS

Monoclonal Gammopathy Of Undetermined Significance and Risk Of Lymphoid and Myeloid Malignancies: 743 Cases Followed For Up To 30 Years In Sweden

Elevated Risk of Venous but Not Arterial Thrombosis in Waldenström's Macroglobulinemia and Lymphoplasmacytic Lymphoma

Multiple Myeloma and Infections: A Population-Based Study Based On 9,610 Multiple Myeloma Patients

Family History of Venous Thromboembolism As a Risk Factor for Thrombosis in Multiple Myeloma Patients: A Population-Based Study,

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only